FDA Investigator Ling Yu L Liu
Ling Yu L Liu has conducted inspections on 68 sites in 1 countries as of 07 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
68
Last Inspection Date:
07 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Ling Yu L Liu:
Alexandra B Pitkin,
Aliza Chalapong Asawesna,
Alyssa T Juguilon,
Alyssa T Vasquez,
Amalia C Himaya,
Amanda L Fyles,
Amir Alavi,
Andy B Lee,
Anita L Liu,
Arnold C Shih,
Aron T Kifle,
Arsen Karapetyan,
Ashar P Parikh,
Ashley J Allen Gaines,
Babajide Michael Osunsanmi,
Barbara J Rincon,
Bichsa T Tran,
Binh T Nguyen,
Brian J Ryan,
Brien C Fox,
Bruce D Broidy,
Bryan A Galvez,
Burnsb,
Bush,
Carla J Lundi,
Carrie A Hughes,
Caryn M Everly,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
Cathryn M Groehnert,
Celena Ngo,
Chelsea N Sealey,
Christina D Mello,
Courtney R Ingalsbe,
Cristina E Mosquera,
Cristina Resendiz Navarrete,
Crystal Monroy,
Daniel J Munoz,
Danielle M Didonna,
Darrin E Davis,
David C Thomas,
David Serrano,
Davis,
Debbie K Giang,
Deborah W Hsu,
Debra C Yamane,
Debra J Fracassa,
Dejon N Harris,
Dennis N Hoang,
Desiree C Iya,
Durell L Giles,
Dyana K Stone,
Elizabeth Ad Girard,
Ellen N Stewart,
Eric C Andes,
Eric Leung,
Fallon J Ryan,
Fe Q Reyes,
Francisco,
Geraldine M Peregrin,
Gordon Chu,
Grace P Santos,
Greg K Keshishyan,
Gulshan R Anand,
Henry E Carrillo,
Herminio C Francisco,
Himanshu Gupta, PhD,
Homero W Aguilar,
Hossein Khorshidi, PhD,
Iris C Macinnes,
James A Barreto,
James B Arnett,
James P Stallings,
James R Fleckenstein,
Jason T Tuuao,
Jeannie Pradyanata,
Jeff M Uriarte,
Jeffrey P Raimondi,
Jennifer M Gogley,
Jennifer P Le,
Jessica L Andrade,
Jinnie Kokiatkulkij,
John A Gonzalez,
John A Liu,
John C Su,
John P Jorgensen,
Jolanna A Norton,
Jonathan R Ormond,
Joseph C Francisco,
Joseph C Yen,
Joseph H Lam,
Judy C Nepsa,
Julia Ventura,
Julie A Rorberg,
Julie A Stocklin,
Karen L Bauer,
Katherine E Jacobitz,
Katie T Duong,
Keeshunna D Daniels,
Kelvin X Sanders,
Kevin Lee,
Kevin T Gerrity,
Kham Phommachanh,
Khang K Pham,
Kibily D Dembele,
Kim Lthomas Cruse,
Kimberly M Lichter,
Lakecha N Lewis,
Lillian S Wu,
Lilly O Barton,
Lin Liu,
Linda H Sirisuk,
Lourdes M Countee,
Marcus F Yambot,
Mark C Saale,
Mark W Babbitt,
Matthew C Kristof,
Melody M Ragasa Leong,
Michael D Garcia,
Michael F Schuette,
Michael J Chan,
Michael P Dimaano,
Michael S Call,
Michael T Cyrus,
Michele R Douglas,
Naveen B Walker,
Nicholas J Lahey,
Nicholas L Hunt,
Ounchith J Phabmixay,
Pamela Y Lee,
Phal K Chhun,
Philip F Istafanos, DMV, MS,
Phillip L Toy,
Rachel C Stanton,
Richard C Chiang,
Robert C Coleman,
Robert C Hoover,
Rumany C Penn, PharmD,
Ryan J Borges,
Sabrina J Dethloff,
Saied A Asbagh,
Selene T Torres,
Sonya L Karsik, RAC,
Sorana Black,
Srinivas R Chennamaneni, PhD,
Stephanie A Slater, MS,
Stuart Kim,
Sue Lee Chan,
Sundy V Sedwick,
Susanna N Choi,
Sylvia A Thomas,
Tamala P Bogan,
Tamala P Magee,
Tamara L Alexander,
Terrance L Thomas,
Terrance P Nguyen,
Terri L Dodds,
Thao T Kwan,
Thomas J Arista,
Tony J Wu,
Truong Xuan Nguyen (Andy),
Trushani T Desai,
Uttaniti Limchumroon (Tom),
Vickie L Anderson,
Victoria C Yang,
Virgilio F Pacio, CSO,
Walden H Lee,
Wayne L Jefferson,
Wendy S Antonowsky,
Xiaohui Shen,
Yvonne Y Wu,
Zachary A Bogorad
Ling Yu L Liu's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2014 | FDA 483 | Amphastar Pharmaceuticals, Inc. - Form 483, 2014-08-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more